HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberto J Firpi Selected Research

Infections

7/2015Hepatitis C: Treatment of difficult to treat patients.
7/2015Hepatitis C cirrhosis: New perspectives for diagnosis and treatment.
11/2011Management of recurrent hepatitis C infection after liver transplantation.
1/2010The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
5/2008Management of viral hepatitis in hematologic malignancies.
12/2007Is early recurrence of hepatitis C associated with biliary anastomotic stricture after liver transplantation?
1/2006Viral hepatitis: manifestations and management strategy.
10/2004One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
2/2004Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
11/2002Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberto J Firpi Research Topics

Disease

14Hepatitis C
04/2014 - 11/2002
10Infections
07/2015 - 11/2002
8Fibrosis (Cirrhosis)
07/2015 - 11/2002
3Chronic Hepatitis C
07/2015 - 01/2003
2Liver Diseases (Liver Disease)
07/2015 - 05/2008
2End Stage Liver Disease
09/2009 - 05/2006
2Hepatitis B
05/2008 - 01/2006
2Virus Diseases (Viral Diseases)
05/2008 - 01/2003
2Hepatitis
05/2008 - 11/2002
1Mesothelioma
01/2018
1Malignant Mesothelioma
01/2018
1Hepatocellular Carcinoma (Hepatoma)
07/2015
1Non-alcoholic Fatty Liver Disease
06/2014
1Alcoholic Fatty Liver
06/2014
1Obesity
06/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2014
1Disease Progression
09/2009
1Hematologic Neoplasms (Hematological Malignancy)
05/2008
1Pathologic Constriction (Stenosis)
12/2007
1Chronic Renal Insufficiency
05/2006
1Herpes Simplex
01/2006
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2006
1Cytomegalovirus Infections (Inclusion Disease)
10/2004
1Nephrogenic Fibrosing Dermopathy
03/2004
1Inflammation (Inflammations)
02/2004

Drug/Important Bio-Agent (IBA)

7Antiviral Agents (Antivirals)IBA
07/2015 - 11/2002
3Ribavirin (Virazole)FDA LinkGeneric
01/2010 - 11/2002
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2010 - 01/2006
2InterferonsIBA
09/2009 - 02/2004
2Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2008 - 01/2006
1AsbestosIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
07/2015
1CreatinineIBA
05/2006
1NucleosidesIBA
01/2006
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2003
1Interferon alpha-2 (Roferon-A)FDA Link
11/2002
1RNA (Ribonucleic Acid)IBA
11/2002

Therapy/Procedure

16Liver Transplantation
07/2015 - 11/2002
7Therapeutics
01/2010 - 11/2002
2Transplantation
06/2014 - 09/2009
2Drug Therapy (Chemotherapy)
06/2014 - 05/2008
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
05/2008 - 01/2006
1Warm Ischemia
10/2004
1Aftercare (After-Treatment)
02/2004